Skip to content

A Study to Assess Non-Invasive Subcutaneous Fat Reduction in the Submental, Inner Thigh and Back/Bra Areas With the CoolSculpting Elite System

Study to Collect Post-Market Data on Non-Invasive Subcutaneous Fat Reduction in the Submental, Inner Thigh and Back/Bra Areas With the CoolSculpting Elite System

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07122583
Enrollment
102
Registered
2025-08-14
Start date
2025-07-22
Completion date
2026-08-31
Last updated
2026-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-Surgical Fat Reduction

Keywords

Non-Surgical Fat Reduction, CoolSculpting Elite System

Brief summary

The primary objective of this protocol is the continued collection of data specific to the submental, inner thigh and back/bra body areas with CoolSculpting Elite. The study aims to collect post-market safety data while allowing for the collection of standardized photos and satisfaction questionnaires after treatment with commercial treatment parameters.

Interventions

CoolSculpting Elite Applicator

Sponsors

AbbVie
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
22 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Participant has clearly visible fat on the submental, bilateral inner thigh or bilateral back/bra areas, which in the investigator's opinion, is appropriate for treatment with CoolSculpting Elite. * Participant has not had weight change exceeding 5% of body weight in the preceding month.

Exclusion criteria

* Participant has had a recent surgical procedure in the area of intended treatment within the previous 6 months. * Participant has had previous surgical or invasive fat reduction procedure (e.g., liposuction, mesotherapy) in the area of intended treatment. * Participant has had a non-invasive fat reduction and/or body contouring procedure in the area of intended treatment within the previous 12 months.

Design outcomes

Primary

MeasureTime frameDescription
Number of Participants with Device and/or Procedure-Related Adverse Events (AEs)Up to Approximately 6 MonthsFrequency of device and procedure-related AEs including serious device-related adverse events (SADEs), will be analyzed per cohort.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026